Criteria for a Clinically Informative Serum Biomarker in Acute Ischaemic Stroke: A Review of S100B

Publisher： Karger

E-ISSN： 1421-9786|27|3|295-302

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.27, Iss.3, 2009-02, pp. : 295-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Protein S100β is a Diagnostic Biomarker for Distinguishing Posterior Circulation Stroke from Vertigo of Nonvascular Causes

By  

European Neurology, Vol. 72, Iss. 5-6, 2014-10 ,pp. : 278-284

Karger

Access to resources Recommend Favorite

Complications of Acute Ischaemic Stroke

By  

Cerebrovascular Diseases, Vol. 8, Iss. 2, 1998-03 ,pp. : 124-132

Karger

Access to resources Recommend Favorite

Acute Treatment of Ischaemic Stroke

By  

Cerebrovascular Diseases, Vol. 17, Iss. 2, 2004-01 ,pp. : 30-46

Karger

Access to resources Recommend Favorite

Thrombolytic Therapy in Acute Ischaemic Stroke

By  

Cerebrovascular Diseases, Vol. 13, Iss. 3, 2002-03 ,pp. : 163-167

Karger

Access to resources Recommend Favorite

Associations between Serum Selenium and Total Plasma Homocysteine during the Acute Phase of Ischaemic Stroke

By  

European Neurology, Vol. 60, Iss. 6, 2008-09 ,pp. : 298-303

Karger

Access to resources Recommend Favorite